Pnc Financial Services Group, Inc. Spero Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$8.96 - $14.12 $125 - $197	-14 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.27 - $14.18 $101 - $198	14 New	14 $0
Q1 2020 May 08, 2020	SELL	$5.27 - $10.41 $168,640 - $333,120	-32,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$6.26 - $13.31 $101,412 - $215,622	16,200 Added 102.53%	32,000 $0
Q4 2018 Feb 08, 2019	BUY	$5.69 - $11.28 $33,002 - $65,423	5,800 Added 58.0%	15,800 $97,000
Q2 2018 Aug 10, 2018	BUY	$10.41 - $17.85 $104,100 - $178,500	10,000 New	10,000 $0

14.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $29.1M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.